JRSIS HEALTH CARE Corp JRSS
JRSIS HEALTH CARE Corp (JRSS) earns a Piotroski F-score of 6/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2023 revenue was $3.5M at a -2.3% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
Beneish M-score: -3.93 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
How it ranks in Services · percentile among 941 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 6/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.208 |
| Retained earnings / assets | -1.605 |
| EBIT / assets | -0.088 |
| Equity / liabilities | -0.07 |
Sector peers · similar-size Services companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| JRSS | JRSIS HEALTH CARE Corp | 6/9 | -7.26 | — | — |
| MD | Pediatrix Medical Group, Inc. | 6/9 | 2.05 | 12.3 | -4.9% |
| SEM | SELECT MEDICAL HOLDINGS CORP | 5/9 | 1.45 | 14 | +5.1% |
| EHC | Encompass Health Corp | 7/9 | — | 17.8 | +10.5% |
| GOOG | Alphabet Inc. | 5/9 | 6.79 | 31.1 | +15.1% |
| MSFT | MICROSOFT CORP | 6/9 | 4.49 | 27.2 | +14.9% |
| META | Meta Platforms, Inc. | 4/9 | 5.34 | 23.1 | +22.2% |
FAQ
Is JRSS financially healthy?
JRSIS HEALTH CARE Corp's Piotroski F-score is 6/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does JRSS pay a dividend?
No, JRSIS HEALTH CARE Corp does not currently pay a dividend.
How profitable is JRSS?
In FY2023, JRSIS HEALTH CARE Corp had a net margin of -2.3%.
Source: SEC EDGAR filings · CIK 0001597892 · US · as of 2023-12-31. facts plus Stocktoria's own computed scores — not investment advice.